Ventyx Biosciences, Inc. - stock earnings
VTYX Quarterly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023Q4 | -46.8 million USD | ? USD |
| 2023Q3 | -54.0 million USD | ? USD |
| 2023Q2 | -53.3 million USD | ? USD |
| 2023Q1 | -35.3 million USD | ? USD |
| 2022Q4 | -35.1 million USD | ? USD |
| 2022Q3 | -29.5 million USD | ? USD |
| 2022Q2 | -19.6 million USD | ? USD |
| 2022Q1 | -22.7 million USD | ? USD |
| 2021Q4 | -17.8 million USD | ? USD |
| 2021Q3 | -12.8 million USD | ? USD |
| 2021Q2 | -15.6 million USD | ? USD |
| 2021Q1 | -37.6 million USD | ? USD |
| 2020Q4 | -16.7 million USD | ? USD |
| 2020Q3 | -7.2 million USD | ? USD |
VTYX Yearly earnings
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -193.0 million USD | ? USD |
| 2022 | -108.0 million USD | ? USD |
| 2021 | -78.4 million USD | ? USD |
| 2020 | -28.5 million USD | ? USD |
| 2019 | -4.5 million USD | ? USD |
VTYX
Price: $4.68
52 week price:
Earnings Per Share: -3.30 USD
P/E Ratio: -0.70
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Volume: 2.2 million
Market Capitalization: 345.1 million